The Department of the Treasury is seeking quotes for a Capillary Electrophoresis (CE) Instrument, with a performance period from August 1, 2026, to July 31, 2027. This opportunity is open to all businesses as there is no set-aside, and it falls under NAICS 334516. Interested vendors should note that this is a combined synopsis/solicitation, meaning they must submit quotes directly without a separate written solicitation. The award will go to the lowest priced technically acceptable offer, so emphasis on meeting the specified technical requirements is crucial.
Analysis by Mindy, grounded in the SAM.gov notice.
Description
Fiscal Service Procurement on behalf of the Alcohol and Tobacco Tax and Trade Bureau (TTB) has a Request for Quote (RFQ) for the purchase of a Capillary Electrophoresis (CE) Instrument.
Period of Performance: 8/1/26 - 7/31/27
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
Award will be made to the offeror with the lowest price technically acceptable quote. Technical acceptability will be determined by comparing quotations with the requirements of this solicitation. To be considered technically acceptable, all quotes must include features and specifications in accordance with the attached salient characteristics.
An all-inclusive firm fixed price award will be made to the contractor whose quote represents the lowest priced technically acceptable quote. Additional discounts are requested. The Government intends to make one award from responses received.
Delivery Location: BELTSVILLE MD 20705
Source: SAM.gov, as posted. Verify the current solicitation before responding.
Pursue this opportunity with Mindy
See who holds it now, who else is bidding, and draft your response — grounded in real government data, not generic AI.